- Home
- KEY vs BAX Comparison
KEY vs BAX Comparison
Compare KEY & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEY
- BAX
- Stock Information
- Founded
- KEY 1825
- BAX 1931
- Country
- KEY United States
- BAX United States
- Employees
- KEY N/A
- BAX N/A
- Industry
- KEY Major Banks
- BAX Medical/Dental Instruments
- Sector
- KEY Finance
- BAX Health Care
- Exchange
- KEY Nasdaq
- BAX Nasdaq
- Market Cap
- KEY 18.5B
- BAX 15.1B
- IPO Year
- KEY N/A
- BAX N/A
- Fundamental
- Price
- KEY $17.65
- BAX $31.49
- Analyst Decision
- KEY Buy
- BAX Hold
- Analyst Count
- KEY 18
- BAX 10
- Target Price
- KEY $19.31
- BAX $40.90
- AVG Volume (30 Days)
- KEY 11.6M
- BAX 4.7M
- Earning Date
- KEY 01-21-2025
- BAX 02-06-2025
- Dividend Yield
- KEY 4.64%
- BAX 3.31%
- EPS Growth
- KEY N/A
- BAX N/A
- EPS
- KEY N/A
- BAX 0.21
- Revenue
- KEY $4,239,000,000.00
- BAX $15,062,000,000.00
- Revenue This Year
- KEY N/A
- BAX N/A
- Revenue Next Year
- KEY $25.38
- BAX $6.57
- P/E Ratio
- KEY N/A
- BAX $148.15
- Revenue Growth
- KEY N/A
- BAX 32.37
- 52 Week Low
- KEY $13.11
- BAX $28.34
- 52 Week High
- KEY $20.04
- BAX $44.01
- Technical
- Relative Strength Index (RSI)
- KEY 49.99
- BAX 60.60
- Support Level
- KEY $17.67
- BAX $30.12
- Resistance Level
- KEY $18.37
- BAX $31.20
- Average True Range (ATR)
- KEY 0.43
- BAX 0.72
- MACD
- KEY 0.14
- BAX 0.38
- Stochastic Oscillator
- KEY 60.44
- BAX 96.63
About KEY KeyCorp
With assets of over $180 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.